Midday movers: Bristol-Myers, 3M and Deckers rise; Dexcom falls

Charter Communications (CHTR) PT Raised to $425 at Evercore ISI

Evercore ISI analyst Vijay Jayant raised the price target on Charter Communications (NASDAQ: CHTR) to $425.00 (from $350.00) while maintaining a Outperform rating.

The analyst comments "Charter reported broad-based upside across nearly every line item that matters in the face of decidedly negative (though, more recently,... More

Apple price target raised at TD Cowen on AI upgrades

TD Cowen analysts raised their price target for Buy-rated Apple (NASDAQ: AAPL) to $250 from $220, citing anticipated upgrades in artificial intelligence (AI) and favorable trends in emerging markets.

In their latest note, the firm projects a positive outlook for Apple's iPhone and other product lines, highlighting potential growth driven by AI enhancements and strong gross margins.

TD Cowen models Apple to report 4% year-over-year revenue growth for the June... More

Norfolk Southern (NSC) PT Raised to $285 at Loop Capital

Loop Capital analyst Ric Paterson raised the price target on Norfolk Southern (NYSE: NSC) to $285.00 (from $278.00) while maintaining a Buy rating.

The analyst comments "Norfolk Southern's recent operating improvements are now finding their way into the company's financials, with a nice upside... More

Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at Goldman Sachs

Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "BMY's noteworthy outperformance on Friday July 26 (+~11% vs. flat XLV), while it occurred amidst favorable shifts in the broader market macro backdrop, was earned, in our... More

Charter Communications (CHTR) PT Raised to $329 at Rosenblatt

Rosenblatt analyst Barton Crockett raised the price target on Charter Communications (NASDAQ: CHTR) to $329.00 (from $292.00) while maintaining a Neutral rating.

The analyst comments "New PT -- Charter's shares now looking more volatile around earnings than Netflix's -- rising nearly 17% Friday in reaction to... More

Saia Inc. (SAIA) PT Lowered to $480 at Benchmark

Benchmark analyst Chris Kuhn lowered the price target on Saia Inc. (NASDAQ: SAIA) to $480.00 (from $575.00) while maintaining a Buy rating.

The analyst comments "We maintain our Buy rating but, for the second consecutive quarter, lower our estimates and price target (now $480 from $575) after Saias 2Q report on Friday. Like the first quarter it was another rough day for the stock,... More

Baker Hughes (BKR) PT Raised to $42 at Benchmark

Benchmark analyst Kurt Hallead raised the price target on Baker Hughes (NASDAQ: BKR) to $42.00 (from $40.00) while maintaining a Buy rating.

The analyst comments "OFSE EBITDA margins are expected to hit 19% in the 4Q24 which puts BKRs target of 20% in 2025 easily in reach.... More

Norfolk Southern (NSC) PT Raised to $270 at Benchmark

Benchmark analyst Nathan Martin raised the price target on Norfolk Southern (NYSE: NSC) to $270.00 (from $266.00) while maintaining a Buy rating.

The analyst comments "Norfolk Southern (NSC) reported 2Q adjusted EPS of $3.06, topping the $2.86 consensus and our $2.92 estimate driven by continued progress on service and... More

Biogen (BIIB) PT Lowered to $294 at Baird

Baird analyst Brian Skorney lowered the price target on Biogen (NASDAQ: BIIB) to $294.00 (from $316.00) while maintaining a Outperform rating.

The analyst comments "Lowering target on negative CHMP opinion. The initial negative opinion jeopardizes Leqembi's launch in the EU, where we had... More

Baker Hughes (BKR) PT Raised to $43 at BofA Securities

BofA Securities analyst Saurabh Pant raised the price target on Baker Hughes (NASDAQ: BKR) to $43.00 (from $39.00) while maintaining a Buy rating.

The analyst comments "Baker Hughess 2Q24 EBITDA was 8% ahead of the Street. The results demonstrated the strength of the cycle beyond the LNG... More

Aon Corp (AON) PT Raised to $335 at RBC Capital

RBC Capital analyst Mark Dwelle raised the price target on Aon Corp (NYSE: AON) to $335.00 (from $315.00) while maintaining a Sector Perform rating.

The analyst comments "Though overall Q2 results lagged our estimates, it was based on the tax rate and other... More

3M (MMM) PT Raised to $95 at RBC Capital

RBC Capital analyst Deane Dray raised the price target on 3M (NYSE: MMM) to $95.00 (from $93.00) while maintaining a Underperform rating.

The analyst comments "Underperform-rated 3M reported strong 2Q24 revenue/margin upside across the portfolio in CEO Bill Browns debut quarter. Heres what drove the... More

Baker Hughes (BKR) PT Raised to $43 at Goldman Sachs

Goldman Sachs analyst Neil Mehta raised the price target on Baker Hughes (NASDAQ: BKR) to $43.00 (from $39.00) while maintaining a Buy rating.

The analyst comments "We continue to recommend Baker Hughes shares where the company's defensive portfolio of relatively more industrial offerings is likely to continue to... More

Baker Hughes (BKR) PT Raised to $43 at JPMorgan

JPMorgan analyst Arun Jayaram raised the price target on Baker Hughes (NASDAQ: BKR) to $43.00 (from $42.00) while maintaining a Overweight rating.

The analyst comments " In the third quarter of 2022, BKR announced a strategic transformation that included a streamlined organizational structure and the appointment of several new leaders including CFO Buese and IET EVP Ramaswamy to execute the companys strategy and lead the company forward. These bold moves by CEO Simonelli to install better athletes into leadership roles has led to more consistent operational and financial performance. This does feel like a... More

Baker Hughes (BKR) PT Raised to $44 at Citi

Citi analyst Scott Gruber raised the price target on Baker Hughes (NASDAQ: BKR) to $44.00 (from $42.00) while maintaining a Buy rating.

The analyst comments "Beat and raises have been rare in OFS, but BKR delivered a solid one in 2q. Beyond managing some... More

Deutsche Bank Upgrades 3M (MMM) to Buy

Deutsche Bank analyst Nicole DeBlase upgraded 3M (NYSE: MMM) from Buy to Buy with a price target of $150.00 (from $110.00).

The analyst comments "Since Bill Brown's appointment to the CEO role in mid-March, we have heard nothing but positive anecdotes from colleagues and investors about his legacy at L3Harris (ticker:... More

Aon Corp (AON) PT Raised to $323 at Morgan Stanley

Morgan Stanley analyst Bob Huang raised the price target on Aon Corp (NYSE: AON) to $323.00 (from $296.00) while maintaining a Equalweight rating.

The analyst comments "Although headline EPS was below expectation, this was due to below the line items such as taxes and interest... More

Aon Corp (AON) PT Raised to $338 at Evercore ISI

Evercore ISI analyst David Motemaden raised the price target on Aon Corp (NYSE: AON) to $338.00 (from $310.00) while maintaining a In Line rating.

The analyst comments "Bottom Line: The result was a positive surprise in CRS organic that more than outweighs the EPS and... More

Charter Communications (CHTR) PT Raised to $435 at Pivotal Research

Pivotal Research analyst Jeffrey Wlodarczak raised the price target on Charter Communications (NASDAQ: CHTR) to $435.00 (from $400.00) while maintaining a Buy rating.

The analyst comments "Charter reported better than expected 2Q results and implied 2H guidance highlighted by lower than forecast data losses, better than expected 2Q revenue (+0.2%) and EBITDA (~+3%) growth, higher than forecast 2Q free cash flow (partly working... More

Goldman Sachs Reiterates Buy Rating on Biogen (BIIB), 'We next await the August 1 earnings call'

Goldman Sachs analyst Salveen Richter reiterated a Buy rating and $342.00 price target on Biogen (NASDAQ: BIIB)

The analyst comments "The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion for BIIB/Eisais Leqembi, stating that the slowing of cognitive decline in treated patients does not outweigh the safety risks... More

Baker Hughes (BKR) PT Raised to $46 at Evercore ISI, 'Momentum Continues To Build'

Evercore ISI analyst James West raised the price target on Baker Hughes (NASDAQ: BKR) to $46.00 (from $42.00) while maintaining a Outperform rating.

The analyst comments "Momentum Continues To Build. Baker continues to improve and optimize its performance by capitalizing on opportunities in the... More

Apple stock now seen as 'a more stable AI play for volatile times'

Raymond James analysts have lifted their stock price target on Apple (NASDAQ: AAPL) to $250 from $200 a share, describing the company as "a more stable AI play for volatile times."

The firm, which maintained an Outperform rating on the stock, said in its F3Q24 preview that it expects a slight beat in results and an outlook largely in line with previous expectations.

This optimism... More